Work

67eP A two-gene signature based on HOXA5 and CEACAM16 predicts survival in IDH-Mutant glioma

Year: 2025

Type: article

Abstract: Isocitrate dehydrogenase-mutant (IDHmut) lower-grade gliomas (LGGs) generally provide a survival advantage over IDH-wildtype glioma. However, little is known about genetic factors that influence their survival. A more comprehensive understanding of these factors would help better prognosticate for patients with IDHmut glioma.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101150

Authors: M.A. Al-Asadi, H. Khudhur, M.K. Hashki, M.B. Ghanameh, E. Noch

Institutions: Jordan University of Science and Technology, Shaikh Khalifa Medical City, The University of Texas Southwestern Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,340